GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the L317I mutant of the chicken C-src tyrosine kinase domain complexed with imatinib

Analyse Crystal structure of the L317I mutant of the chicken C-src tyrosine kinase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3OEZ
Type
protein
Length
522 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
STI
Pockets
3 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26143% helix, 16% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26140% helix, 16% strandP00523

Ligands and binding sites

  • STI · 4-(4-methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide · ligand · 2 copies · chains A, B
  • ACT · Acetate ion · additive · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16460.750.8171STI
23970.710.8250STI
32940.590.7840empty

Interfaces

1 interface between chains.

  • A–B · 410 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 3OEZ · crystal structure of the L317I mutant of the chicken c-Src tyrosine kinase domain… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.